期刊
HEPATOLOGY
卷 53, 期 1, 页码 181-192出版社
WILEY-BLACKWELL
DOI: 10.1002/hep.24015
关键词
-
资金
- National Natural Science Foundation of China [30921006, 81071778]
- State Key Project for Infectious Diseases [2008ZX10002, 2006AA02A310, 2007CB914502]
- Key Program of Basic Research of Shanghai, China [10JC1418500, 08ZR1405500, 06Z059-08Z20]
The overall survival of patients with hepatocellular carcinoma (HCC) remains poor, and the molecular mechanisms underlying HCC progression and aggressiveness are unclear. Here, we report that increased expression of p28(GANK) (Gankyrin, PSMD10, or p28) in human HCC predicts poor survival and disease recurrence after surgery. Patients with HCC who have large tumors, with vascular invasion and intrahepatic or distant metastasis, expressed high levels of p28(GANK). Invasive tumors overexpressing p28(GANK) were featured by active epithelial-mesenchymal transition (EMT), and exhibited increased angiogenesis associated with vascular endothelial growth factor overexpression, whereas silencing p28(GANK) expression attenuated EMT and motility/invasion of tumor cells. The p28(GANK) activates phosphoinositide 3-kinase (PI3K)-V-akt Murine Thymoma Viral Oncogene Homolog (AKT)-hypoxia-inducible factor 1 alpha (HIF-1 alpha) signaling to promote TWIST1, vascular endothelial growth factor, and metalloproteinase 2 expression. Suppression of the PI3K-AKT-HIF-1a pathway interfered with p28(GANK)-mediated EMT and invasion. Consistently, we detected a significant correlation between p28(GANK) expression and p-AKT levels in a cohort of HCC biopsies, and the combination of these two parameters is a more powerful predictor of poor prognosis. Conclusion: These results present novel mechanistic insight into a critical role of p28(GANK) in HCC progression and metastasis. (HEPATOLOGY 2011;53:181-192)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据